Related Experiment Videos
The therapeutic dilemma of hypertension in the elderly
1University of Michigan, Ann Arbor.
Insights
Treating hypertension in older adults is recommended to reduce cardiovascular risks. While it lowers stroke incidence and may improve cardiovascular health, it does not extend lifespan, necessitating a balanced treatment approach.
Area of Science:
- Gerontology
- Cardiology
- Pharmacology
Background:
- Elevated blood pressure (hypertension) is a significant risk factor for cardiovascular disease (CVD) morbidity and mortality across all age groups.
- The elderly population (over 65 years) presents unique considerations for hypertension management due to potential comorbidities and altered drug responses.
Purpose of the Study:
- To evaluate the benefits and limitations of antihypertensive treatment in elderly individuals.
- To guide the optimal management strategy for hypertension in older adults, balancing efficacy with safety.
Main Methods:
- Review of treatment trials focusing on antihypertensive therapies in elderly populations.
- Analysis of cardiovascular outcomes, including stroke, overall morbidity, and mortality.
- Consideration of drug-specific side effects and patient-specific factors in treatment individualization.
Main Results:
- Antihypertensive treatment in the elderly is associated with a reduction in stroke incidence.
- Treatment may lead to improvements in cardiovascular morbidity but has not been shown to prolong life.
- No current antihypertensive medications are specifically designed for the elderly population.
Conclusions:
- Hypertension in individuals over 65 should be treated, but an aggressive approach is not warranted.
- Individualized treatment plans, considering drug side effects and patient characteristics, are crucial for optimizing outcomes.
- Ongoing research and development of new antihypertensive agents aim to further enhance cardiovascular disease prevention in the elderly.
Abstract:
There are good reasons to treat hypertension in the elderly. Elevated blood pressure at any age increases morbidity and mortality from cardiovascular disease. Treatment trials suggest that antihypertensive treatment in the elderly decreases strokes, may improve the cardiovascular morbidity, but does not prolong life. Consequently, elevated blood pressure in people over 65 years of age should be treated, but there is no justification for an overly aggressive approach. Knowledge of side effects of various drugs and appreciation of a patient's specific features permit individual 'tailoring' of the treatment and optimise the outcome. No present-day antihypertensive drugs are specific for the elderly. The drive to combat cardiovascular morbidity and mortality in the elderly continues. New drugs are under development and promise to further improve results.